简
繁
EN
Home
About Us
Corporate Profile
Development
Company Honor
Products
Structural Heart Diseases
Product Profile
Business
Commercialization
Collaboration
R&D and Production
R&D Center
Production
News Center
News
Press Release
Investor Relations
Announcements
Financial Reports
Corporate Governance
Careers
Life at Jenscare
Join Us
News Center
Scroll
Media Center
News Center
News
Press Release
葛均波院士团队成功应用Lux-Valve Plus完成经血管介入三尖瓣置换临床前研究!
2021-11-14
Press Release
2021年11月14日星期日,复旦大学附属中山医院(以下简称中山医院)葛均波院士团队成功应用经血管介入三尖瓣置换产品Lux-Valve Plus...
Learn More
The One-Year Outcome of LuX-Valve Plus TRAVEL II Study was Officially Released at TCT 2024
2024-11-04 Press Release
WASHINGTON, Oct. 31, 2024 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("J...
多国专家于AVAM会议携手完成一例大尺寸LuX-Valve Plus手术直播
2024-10-06 Press Release
2024年10月2日至4日,由法国波尔多大学医学中心、PCR大会共同主办的AVAM2024会议(2024 Atrio Ventricular Academy M...
中国-巴西心血管创新论坛 | 厦心王焱教授团队成功应用国产三尖瓣置换器械LuX-Valve Plus向巴西手术直播
2024-10-04 Press Release
2024年9月26-27日,由厦门大学附属心血管病医院(简称“厦心医院”)和巴西梅塞亚纳医院(Hospital de Messejana...
Jenscare, with innovative TTVR, releases 2024H1 interim results
2024-08-29 Press Release
BEIJING, Aug. 28, 2024 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jens...
重磅|健世科技 Lux-Valve成为中国首款同时获得美国FDA突破性器械及NMPA创新通道认定的瓣膜介入治疗器械
2021-11-07 Press Release
宁波健世科技股份有限公司开发的Lux-Valve经导管人工三尖瓣瓣膜置换系统获得美国FDA授予的突破性器械认定,用于治疗重度三尖瓣返流患者。 三尖...
重磅 |《2021欧洲心脏病学会/心胸外科协会瓣膜性心脏病管理指南》首次纳入健世科技经导管三尖瓣介入治疗临床研究数据
2021-09-06 Press Release
2021年8月30日,欧洲心脏病学会年会(ESC 2021)于英国伦敦会展中心落幕。作为世界上规模大、具影响力的心血管学...
<
1
2
>
Home
About Us
Corporate Profile
Development
Company Honor
Products
Structural Heart Diseases
Product Profile
Business
Commercialization
Collaboration
R&D and Production
R&D Center
Production
News Center
News
Press Release
Investor Relations
Announcements
Financial Reports
Corporate Governance
Careers
Life at Jenscare
Join Us